NasdaqCM - Delayed Quote • USD
Abeona Therapeutics Inc. (ABEO)
At close: 4:00 PM EDT
After hours: 4:31 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.51 | -0.53 | -2.14 | -1.9 |
| Low Estimate | -0.6 | -0.6 | -2.38 | -2.5 |
| High Estimate | -0.47 | -0.46 | -1.92 | -1.38 |
| Year Ago EPS | -0.54 | -0.92 | -2.53 | -2.14 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | 170k | 170k | 500k | 22.83M |
| Low Estimate | -- | -- | -- | 10M |
| High Estimate | 500k | 500k | 2M | 36.7M |
| Year Ago Sales | -- | -- | 3.5M | 500k |
| Sales Growth (year/est) | -- | -- | -85.70% | 4,466.00% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.58 | -0.68 | -0.53 | -0.47 |
| EPS Actual | -0.54 | -0.92 | -0.48 | -0.77 |
| Difference | 0.04 | -0.24 | 0.05 | -0.3 |
| Surprise % | 6.90% | -35.30% | 9.40% | -63.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.51 | -0.53 | -2.14 | -1.9 |
| 7 Days Ago | -0.56 | -0.6 | -1.92 | -1.1 |
| 30 Days Ago | -0.56 | -0.6 | -1.92 | -1.1 |
| 60 Days Ago | -0.51 | -0.5 | -1.71 | -0.36 |
| 90 Days Ago | -0.51 | -0.5 | -1.71 | -0.36 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | -- | -- |
| Up Last 30 Days | 2 | 2 | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 4 | 4 |
Growth Estimates
| CURRENCY IN USD | ABEO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 5.60% | -- | -- | 6.50% |
| Next Qtr. | 42.40% | -- | -- | 12.00% |
| Current Year | 15.40% | -- | -- | 5.30% |
| Next Year | 11.20% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 4/23/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/24/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 7/13/2023 |
| Reiterates | Alliance Global Partners: Buy | 5/24/2023 |
| Maintains | SVB Leerink: Market Perform | 11/14/2022 |
| Maintains | Cantor Fitzgerald: Overweight | 11/8/2022 |
Related Tickers
DAWN Day One Biopharmaceuticals, Inc.
14.92
+12.94%
IBRX ImmunityBio, Inc.
7.35
+43.84%
CDTX Cidara Therapeutics, Inc.
12.63
-2.85%
XFOR X4 Pharmaceuticals, Inc.
1.1650
+3.10%
HEPA Hepion Pharmaceuticals, Inc.
1.3700
+6.20%
MLEC Moolec Science SA
1.4500
+2.11%
HOOK HOOKIPA Pharma Inc.
0.8933
+10.82%
PCSA Processa Pharmaceuticals, Inc.
2.1500
-11.52%
OCUL Ocular Therapeutix, Inc.
4.7450
+12.98%
NKGN NKGen Biotech, Inc.
1.6100
-18.69%